CD59 and coronary artery disorder: In contrast with the protectin pathways, the production of RvD5n-3 DPA, which we recently found to exert vasculo-protective actions [21], was reduced in all STEMI patients at all three intervals tested and in stable CAD patients when compared with healthy volunteers.